Drug Research
Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the Coalition for Epidemic Preparedness Innovations (CEPI) awarded an initial...
News
Albireo Completes Enrollment in Phase 2 Study of Elobixibat...
Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced achievement of full patient enrollment in its Phase 2...
IT & Data Management
Beijing University of Chinese Medicine collaborates with Elsevier to...
Elsevier, a global leader in information analytics, specializing in science and health, launched the first branch of its Traditional Chinese Medicine (TCM) taxonomy in collaboration...
Clinical Trials
Biocair to participate in cell and gene webinar to...
Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, will explore ongoing material sourcing challenges for organisations moving from development to clinical and...
News
Bactiguard Holding AB has completed the acquisition of Vigilenz...
Bactiguard Holding AB has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020.
All conditions...
News
Gilead buys Forty Seven for $4.9 billion to bolster...
Gilead Sciences Inc (GILD.O) said it would buy Forty Seven Inc (FTSV.O) for $4.9 billion in cash, adding an experimental treatment that targets blood cancer...
IT & Data Management
Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology...
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced U.S. FDA clearance of its Basal-IQâ„¢ technology as an interoperable automated glycemic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.